DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 6.63 0.33%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

BMY Crosses Above Key Moving Average Level

3 Stocks Boosting The Drugs Industry Higher

Bristol-Myers Squibb Company (BMY) Highlighted As Storm The Castle Stock

3 Stocks Reiterated As A Buy: MU, BMY, NFLX

Why Bristol-Myers Squibb Loses Out Against This Rival

Bristol-Myers (BMY) Beats on Q2 Earnings, Maintains Outlook - Analyst Blog

Keep Calm and Carry On, Roche Stock

Roche continues to build upon the strongest oncology franchise in Big Pharma but could still use some non-oncology hits

3 Stocks Improving Performance Of The Health Care Sector

Bristol-Myers Squibb's Second-Quarter Reflects a Company in Transition

Bristol-Myers Squibb revenue fell by 4% in the second quarter, due mostly to its exit from the diabetes market.

Q2 2014 Bristol Myers Squibb Earnings Conference Call (Webcast)

See More Articles...